Penserra Capital Management LLC Nurix Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$26.43 - $34.5 $26,826 - $35,017	-1,015 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$22.71 - $36.69 $113 - $183	5 Added 0.5%	1,015 $30,000
Q2 2021 Aug 12, 2021	BUY	$24.21 - $35.89 $3,026 - $4,486	125 Added 14.12%	1,010 $26,000
Q1 2021 May 13, 2021	SELL	$26.98 - $50.17 $134 - $250	-5 Reduced 0.56%	885 $27,000
Q4 2020 Feb 12, 2021	BUY	$22.85 - $48.44 $20,336 - $43,111	890 New	890 $29,000

180

68.1M

78K

53.8K

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $860M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.